-

Barclays Announces New Senior Appointments in Healthcare Investment Banking and in Equity Research

Maneet Singh and Evan Matlin named Co-Heads of M&A Healthcare in the US; Jon Swope to join Healthcare Information Technology Banking team; Stephanie Davis to separately join and lead US Healthcare Technology & Digital Health Equity Research

NEW YORK--(BUSINESS WIRE)--Barclays today announced new senior appointments in Healthcare Investment Banking and in Equity Research. They include the hiring of Maneet Singh and appointment of Evan Matlin as new Co-Heads of Healthcare M&A in the United States, Jon Swope joining the Healthcare Information Technology Banking team, and Stephanie Davis in Equity Research.

As Co-Heads of Healthcare M&A in the US, Singh and Matlin will jointly lead the firm's advisory capabilities across the sector. They will report to Dan Grabos and Larry Hamdan, Co-Heads of Americas M&A, and be based in New York.

“Maneet will partner with Evan to drive strategic dialog with our healthcare clients and ensure we are offering a full suite of sophisticated M&A and capital markets products. His expertise, deep client relationships, and strong track record of managing and leading teams positions us well for continued success in this key market,” said Dan Grabos and Larry Hamdan, Co-Heads of Americas M&A.

Singh brings with him extensive sector knowledge, with previous experience at Goldman Sachs and Credit Suisse. Matlin, who also has extensive experience, joined Barclays in 2016 from Deutsche Bank and has been a senior member of the Healthcare M&A team, having advised on many of the group’s marquee transactions. He has also worked at Barclays in London, leading healthcare M&A for EMEA.

Jon Swope to Join the Healthcare Information Technology Banking Team

Jon Swope will join the Healthcare Information Technology Banking team as a Managing Director in New York, working closely with Jefferson Rives and Michael Jaffe, and reporting to Rick Landgarten, Global Head of Healthcare and Real Estate Banking.

“Technology continues to drive rapid change across all sectors of healthcare. It’s incredibly exciting to see companies advancing technologies to improve clinical outcomes, create a more efficient healthcare payor and payments infrastructure, enable value-based care and ultimately create a more efficient and navigable healthcare system. Jon’s hiring will ensure we continue to broaden our efforts in this critical space,” said Landgarten.

Swope previously worked at SVB Securities, where he led their Digital Health and HealthTech practice, and at Bank of America.

Other recent hires and appointments in Barclays’ Healthcare Investment Banking group include Jim Birchenough as Chairman of Global Healthcare Investment Banking and Co-Head of Global Biopharma Investment Banking, Alexis de Rosnay as Co-Head of Global Biopharma Investment Banking and Chairman of Global Healthcare Investment Banking, and Jeff Ammerman as Global Head of Specialty Pharmaceuticals Investment Banking. Amit Tyagi and John Hagens also recently joined the team as Managing Directors, focusing on healthcare tools and diagnostics and medical technologies, respectively.

“We continue to grow our healthcare coverage footprint across a broad range of sectors in both the US and Europe. We will harness the strengths of our coverage and product franchises to continue our momentum and strengthen our connectivity with new and existing clients,” Landgarten said.

Stephanie Davis to Join US Equity Research

Barclays Research, a separate division, has also made significant investments in its Healthcare coverage.

Stephanie Davis will join Barclays as a Managing Director to lead Barclays’ equity research on the US Healthcare Technology & Digital Health sector. Davis, a top-ranked analyst by Institutional Investor in 2022, previously led SVB Securities’ healthcare technology research franchise. She will report to Rob Rouse, Head of Americas Equity Research.

About Barclays Corporate and Investment Bank
Barclays Corporate and Investment Bank is comprised of the Investment Banking, International Corporate Banking, Global Markets and Research businesses. It provides money managers, financial institutions, governments, supranational organisations and corporate clients with services and advice for their funding, financing, strategic and risk management needs. For further information about Barclays Corporate and Investment Bank, please visit our website www.cib.barclays.

Contacts

Matt Scully
212-526-7844
matthew.scully@barclays.com

Barclays

LSE:BARC
Details
Headquarters: London, United Kingdon
Website: home.barclays
CEO: C.S. Venkatakrishnan
Employees: 81,600
Organization: PUB
Revenues: £21.9bn (2021)
Net Income: £8.4bn (2021)

Release Versions

Contacts

Matt Scully
212-526-7844
matthew.scully@barclays.com

More News From Barclays

Barclays Continues Strategic Investment in Financial Sponsors Group

NEW YORK--(BUSINESS WIRE)--Barclays today announces the appointment of Jason Short as a Managing Director in the Financial Sponsors Group (FSG), based in San Francisco and covering West Coast accounts. Expanding the capabilities with financial sponsor clients is key to the growth of Barclays’ Investment Banking business. In his new role, Jason will be responsible for building and maintaining relationships with financial sponsor clients based on the West Coast and their portfolio company managem...

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa

LONDON--(BUSINESS WIRE)--Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA. This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank. Kieran joins Barclays from Bank of America where he spent 18 years, most recently as a Managing Director in the EMEA Healthcare team. He has...

Barclays Appoints Two New Senior Hires Into Its Financial Sponsors Group

NEW YORK--(BUSINESS WIRE)--Barclays announces the appointments of Isobel van Daesdonk and Scott Willard as Managing Directors within the Financial Sponsors Group. Ms. van Daesdonk and Mr. Willard will be based in New York, and will report to Christian Oberle, Head of the Americas Financial Sponsors Group at Barclays. Ms. van Daesdonk is a seasoned Investment Banker with 25 years of experience. She joins Barclays from Guggenheim Securities, where she was a Senior Managing Director in Financial S...
Back to Newsroom